ArticleNature cancer2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.
Jason L Vassy et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it